Effects of multiple daily injection therapy with humalog® mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus

Clinical Therapeutics

Volumn 26, Issue 4, 2004, Pages 502-510

  Roach, Paris ^a,b   Bai, Shan ^b   Charbonnel, Bernard ^c   Consoli, Agostino ^d   Taboga, Claudio ^e   Tiengo, Antonio ^f   Bolli, Geremia ^f  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITY OF CHIETI   (Italy)

^e SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^f Department of Clinical Medicine ^*  (Italy)

Author keywords

Insulin lispro mix75 25; Intensive insulin treatment

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FRANCE; GLUCOSE ASSAY; GLYCEMIC INDEX; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTPRANDIAL STATE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; TREATMENT OUTCOME;

EID: 2342471306     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(04)90052-5     Document Type: Article

References (15)

1. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin. A rapidly-absorbed analogue of human insulin. Diabetes. 1994;43:396-402.
2. Anderson JH Jr, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients in insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes. 1997;46:265-270.
3. Torlone E, Pampanelli S, Lalli C, et al. Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care. 1996;19:945-952.
4. Del Sindaco P, Ciofetta M, Lalli C, et al. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: Importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med. 1998;15:592-600.
5. Lalli C, Ciofetta M, Del Sindaco P, et al. Long-term intensive treatments of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care. 1999;22:468-477.
6. 1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care. 1999;22:795-800.
7. Colombel A, Murat A, Krempf M, et al. Improvement of blood glucose control in type 1 diabetic patients treated with lispro and multiple NPH injections. Diabet Med. 1999;16:319-324.
8. Roach P, Woodworth JR. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures. Clin Pharmacokinet. 2002;41:1043-1057.
9. Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin®/Humalog® Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther. 2000;22:1049-1067.
10. Roach P, Bolli G, Herz M, Camporeale A, and the Humalog Mixtures Study Group. Intensive therapy with Humalog® mixtures vs. self-mixed insulin lispro and NPH. Diabetes. 2002;51(Suppl 2):A477.
11. World Health Organization. WHO Study Group on Prevention of Diabetes Mellitus. Technical Report Series 844. Geneva: WHO; 1994.
12. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics. 1972;28:577-584.
13. Taulbee JD. A note on the use of nonparametric methods in the statistical analysis of the two-period changeover design. Biometrics. 1982;38:1053-1055.
14. Porcellati F, Rosetti P, Fanelli C, et al. Glargine vs NPH as basal insulin in intensive treatment of T1DM given lispro at meals: One year comparison. Diabetes. 2002;51(Suppl 2):A53. Abstract.
15. Rossetti P, Pampanelli S, Costa E, et al. A three-month comparison between multiple daily NPH and once daily glargine insulin administration in intensive replacement of basal insulin in type 1 diabetes mellitus. Diabetes. 2002;51(Suppl 2):A54. Abstract.